Board of directors (13)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (8)
Company facts
- Chair
- —
- In S&P 500 since
- Dec 2000
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC industry
- Life Insurance
- SEC filings
- EDGAR
Connections to other S&P 500 companies
Current directors and officers who also hold a role at another S&P 500 company.
- Carla A. HarrisCMI · DirectorWMT · Director
- Denise M. MorrisonDGX · DirectorV · Director
- Mark A. WeinbergerJNJ · DirectorJPM · Director
- Michelle SeitzHONA · DirectorMSCI · Director
- William E. KennardT · DirectorF · Director
- Carlos M. GutierrezOXY · Director
- Diana McKenzieVRTX · Director
- Laura J. HayEG · Director
- Marlene DebelRJF · Director
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Marlene Debel EVP & Chief Risk Officer | Sale | 21,312 | $81.59 | $1.7M |
| May 12, 2025 | Bill Pappas EVP, Global Tech. & Ops. | Sale | 26,000 | $80.49 | $2.1M |
| Dec 13, 2024 | Marlene Debel EVP & Chief Risk Officer | Sale | 22,810 | $82.88 | $1.9M |
| Dec 13, 2024 | Michel Khalaf President & CEO | Sale | 20,926 | $82.84 | $1.7M |
| Mar 18, 2024 | Bill Pappas EVP, Global Tech. & Ops. | Sale | 27,000 | $72.27 | $2.0M |
| Mar 13, 2024 | Ramy Tadros President, U.S. Business | Sale | 4,026 | $71.90 | $289K |
| Feb 5, 2024 | Michel Khalaf President & CEO | Sale | 20,460 | $65.95 | $1.3M |
| Aug 9, 2023 | Marlene Debel EVP & Chief Risk Officer | Sale | 9,391 | $63.18 | $593K |
| May 19, 2023 | Jeh C. Johnson Director | Buy | 17 | $51.69 | $879 |
| Mar 2, 2023 | Bill Pappas EVP, Global Tech. & Ops. | Sale | 2,857 | $70.96 | $203K |
| Feb 27, 2023 | Bill Pappas EVP, Global Tech. & Ops. | Sale | 11,345 | $71.96 | $816K |
| Dec 23, 2022 | Robert Glenn Hubbard Director | Sale | 6 | $72.24 | $433 |
| Dec 20, 2022 | Susan M. Podlogar EVP & Chief HR Officer | Sale | 3,000 | $71.91 | $216K |
| Dec 12, 2022 | Steven J. Goulart EVP & Chief Investment Officer | Sale | 29,401 | $71.88 | $2.1M |
| Dec 12, 2022 | Michel Khalaf President & CEO | Sale | 57,201 | $72.49 | $4.1M |
| Dec 7, 2022 | Bill Pappas EVP, Global Tech. & Ops. | Sale | 5,000 | $75.55 | $378K |
| Aug 19, 2022 | Marlene Debel EVP & Chief Risk Officer | Sale | 4,060 | $67.60 | $274K |
| Aug 19, 2022 | Steven J. Goulart EVP & Chief Investment Officer | Sale | 4,060 | $67.60 | $274K |
| May 6, 2022 | Robert Glenn Hubbard Director | Buy | 132 | $67.44 | $9K |
| Feb 8, 2022 | Steven J. Goulart EVP & Chief Investment Officer | Sale | 56,857 | $70.29 | $4.0M |
| Dec 21, 2021 | Michel Khalaf President & CEO | Sale | 42,748 | $60.74 | $2.6M |
| May 19, 2021 | Esther Lee EVP - Gl. Chief Marketing Off. | Sale | 7,800 | $64.76 | $505K |
| May 11, 2021 | Marlene Debel EVP & Chief Risk Officer | Sale | 11,000 | $64.58 | $710K |
| Feb 24, 2021 | John D. McCallion EVP & Chief Financial Officer | Sale | 7,742 | $59.52 | $461K |
| Feb 18, 2021 | Steven J. Goulart EVP & Chief Investment Officer | Sale | 17,055 | $54.94 | $937K |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Feb 24, 2026
On February 24, 2026, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) increased the number of directors serving on the Board from eleven to thirteen, and elected Daniel S. Glaser and Michelle R. Seitz as directors of the Company. The Board appointed Mr. Glaser to its Audit Committee, Compensation Committee, and Finance and Risk Committee, and appointed Ms. Seitz to its Compensation Committee, Governance and Corporate Responsibility Committee, and Investment Committee, each effective immediately. The Board has affirmatively determined that each of Mr. Glaser and Ms. Seitz is an independent director. Each of Mr. Glaser and Ms. Seitz will participate in the Company’s standard non-management director compensation arrangements.
Read the 8-K filing - Jul 30, 2025
On July 30, 2025, MetLife, Inc. (the “Company”) announced the appointment of Adrienne O’Neill as Executive Vice President and Chief Accounting Officer, effective September 2, 2025. A copy of the Company’s news release announcing Ms. O’Neill’s appointment is included in this report as Exhibit 99.1. Ms. O’Neill, age 44, has served as Chief Financial Officer, Asia Segment, of Manulife Financial Corporation (“Manulife”), a global life insurance company and international financial services provider, since February 2025. Previously, she served as Manulife’s Global Controller and Group Chief Accounting Officer from July 2021 to February 2025, and as its Global Head of Investor Relations from September 2018 to June 2021. Since joining Manulife in 2007, Ms.
Read the 8-K filing - Mar 28, 2025
On March 27, 2025, David L. Herzog, a director of MetLife, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to resign from the Board, effective May 1, 2025, and not to stand for re-election at the Company’s 2025 annual meeting of shareholders. Mr. Herzog’s decision to resign was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Read the 8-K filing - Feb 27, 2025
(c) As previously disclosed by MetLife, Inc. (the “Company”), on January 7, 2025, Tamara L. Schock, notified the Company of her intent to resign as Executive Vice President and Chief Accounting Officer of the Company. On February 25, 2025, the Board of Directors (the “Board”) of the Company appointed Toby Srihiran Brown, Executive Vice President and Global Head of Reinsurance of the Company, as the Company’s interim Chief Accounting Officer, to be effective as of March 15, 2025, while a search for a permanent replacement is conducted. Ms. Schock will continue to serve as the Company’s principal accounting officer until Mr. Brown’s appointment is effective. Mr. Brown, age 51, has served in his current role since October 2024. Previously, he served as Executive Vice President and Global Chief Auditor of the Company from March 2020 to September 2024. Since joining the Company in 2010, Mr.
Read the 8-K filing - Jan 10, 2025
On January 7, 2025, Tamara L. Schock, Executive Vice President and Chief Accounting Officer of MetLife, Inc. (the “Company”), informed the Company that she would resign from her position to pursue another opportunity. Ms. Schock’s last day of employment with the Company is expected to be on or about March 14, 2025. Ms. Schock’s decision to resign was due to personal reasons and not as a result of any disagreement with the Company on any matter relating to the Company’s financial statements, internal control over financial reporting, operations, policies or practices.
Read the 8-K filing - Jun 24, 2024
On June 18, 2024, the shareholders of MetLife, Inc. (the “Company”), upon recommendation of the Company’s Board of Directors (the “Board”), approved the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Stock Plan”), which will become effective on January 1, 2025. The Stock Plan provides the Company with the means for granting various types of equity-based compensation to selected employees, including executive officers, of the Company and its affiliates, as well as non-management directors of the Company. The Stock Plan is described in greater detail under Proposal 4 in the Company's definitive proxy statement for the 2024 annual meeting of shareholders, filed with the U.S. Securities and Exchange Commission on April 26, 2024 (the “Proxy Statement”).
Read the 8-K filing - Feb 28, 2024
On February 27, 2024, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) elected Laura J. Hay a director of the Company and appointed Ms. Hay to its Audit Committee and its Finance and Risk Committee, effective immediately. The Board has affirmatively determined that Ms. Hay is an independent director. Ms. Hay will participate in the Company’s standard non-management director compensation arrangements. The Company pays non-management directors a retainer of $325,000 per year, $175,000 payable in shares of the Company’s common stock and $150,000 payable in cash. Directors earn a pro-rated retainer for partial-year service, earning the first of four annual installments at the beginning of service.
Read the 8-K filing - Jun 21, 2023
On June 16, 2023, Steven J. Goulart, Executive Vice President and Chief Investment Officer of MetLife, Inc. (the “Company”) and a named executive officer in the Company’s most recent proxy statement, informed the Company that he will retire on August 31, 2023.
Read the 8-K filing - Mar 1, 2023
On February 28, 2023, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) increased the number of directors serving on the Board from thirteen to fourteen and elected Jeh C. Johnson a director of the Company and appointed Mr. Johnson to its Audit Committee and its Governance and Corporate Responsibility Committee, effective immediately. The Board also affirmatively determined that Mr. Johnson qualifies as an independent director under the Corporate Governance Standards of the New York Stock Exchange and Rule 10A-3 under the Securities Exchange Act of 1934, as amended. Mr. Johnson will participate in the Company’s standard non-management director compensation arrangements. The Company pays non-management directors a retainer of $325,000 per year, $175,000 payable in shares of the Company’s common stock and $150,000 payable in cash.
Read the 8-K filing - Jun 16, 2022
On June 10, 2022, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) appointed Carla Harris to its Governance and Corporate Responsibility Committee and Investment Committee, effective immediately. On April 4, 2022, the Company filed a Current Report on Form 8-K (the “Original Report”) disclosing that the Board elected Ms. Harris a director of the Company, effective April 27, 2022. Committee assignments for Ms. Harris were not determined as of the filing of the Original Report. This Current Report on Form 8-K/A amends the Original Report solely for the purpose of disclosing the information above.
Read the 8-K filing - Apr 4, 2022
On April 4, 2022, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) increased the number of directors serving on the Board from twelve to thirteen and elected Carla Harris a director of the Company, effective April 27, 2022. The Board also affirmatively determined that Ms. Harris qualifies as an independent director under the Corporate Governance Standards of the New York Stock Exchange and Rule 10A-3 under the Securities Exchange Act of 1934, as amended. The Board has not yet appointed Ms. Harris to its committees. MetLife, Inc. will disclose any subsequent committee appointment in an amendment to this Form 8-K. Ms. Harris will participate in the Company’s standard non-management director compensation arrangements. The Company pays non-management directors a retainer of $300,000 per year, 50% in shares of the Company’s common stock and 50% in cash.
Read the 8-K filing - Aug 26, 2019
On August 21, 2019, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) elected Mark A. Weinberger a director of the Company and appointed Mr. Weinberger to its Audit Committee, effective immediately. The Board also affirmatively determined that Mr. Weinberger qualifies as an independent director under the Corporate Governance Standards of the New York Stock Exchange and Rule 10A-3 under the Securities Exchange Act of 1934, as amended. Mr. Weinberger will participate in the Company’s standard non-management director compensation arrangements. The Company pays non-management directors a retainer of $300,000 per year, 50% in shares of the Company’s common stock and 50% in cash. Directors earn a pro-rated retainer for partial-year service, earning the first of four annual installments at the beginning of service. Mr.
Read the 8-K filing - Jun 18, 2019
MetLife, Inc. (the “Company”) and MetLife Group, Inc. entered into a Separation Agreement and General Release with Martin J. Lippert, their former Executive Vice President, Global Head of Technology and Operations, effective June 16, 2019. Mr. Lippert released any claims against the Company and those associated with it. He also agreed not to disparage the Company and those associated with it. Mr. Lippert will also assist and reasonably cooperate with the Company in connection with investigations, audits, examinations, inspections, or proceedings brought against or by the Company or any of its affiliates (together, "MetLife"). The Agreement does not affect Mr. Lippert's previously-disclosed Agreement to Protect Corporate Property. For example, Mr.
Read the 8-K filing - Mar 6, 2019
On February 28, 2019, MetLife, Inc.'s Executive Vice President, Global Head of Technology and Operations, Martin J. Lippert, informed the company that he will retire effective April 30, 2019.
Read the 8-K filing - Mar 5, 2019
Michel A. Khalaf is MetLife, Inc.'s President, U.S. Business and EMEA, and (as MetLife, Inc. has previously announced) will become its President and Chief Executive Officer ("CEO") as of May 1, 2019. MetLife, Inc. affiliates (collectively, the “Company”) and Michel A. Khalaf entered into an amendment to Mr. Khalaf's Letter of Understanding of June 15, 2017 (the "Amendment") on February 27, 2019, and a waiver and release (the “Release”) on March 4, 2019. MetLife, Inc.’s Board of Directors previously approved the terms of each. The Amendment As MetLife, Inc. previously disclosed, in 2017, the Company transferred Mr. Khalaf to the United States from the United Arab Emirates, which has a lower tax structure than that of the U.S. In order to encourage Mr. Khalaf to take the role of President of both the U.S.
Read the 8-K filing
Show 16 older changes
- Jan 8, 2019
SIGNATURES Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 3, 2019, the MetLife, Inc. (the “Company”) Board of Directors (the “Board”) appointed Michel A. Khalaf President and Chief Executive Officer effective May 1, 2019 (the “Effective Date”). The Board also elected Mr. Khalaf a Company director, and appointed him to its Executive Committee, as of the Effective Date. Steven A. Kandarian, the Company’s Chairman of the Board, President and Chief Executive Officer, will serve in those capacities through April 30, 2019 and retire. Mr. Khalaf, age 54, has served as the Company’s President, U.S. Business and Europe, the Middle East, and Africa (“EMEA”) since July, 2017.
Read the 8-K filing - Dec 13, 2018
On December 11, 2018, the Compensation Committee (the “Committee”) of the Board of Directors of MetLife, Inc. (the “Company”) approved modified forms of Performance Share Agreement and Performance Unit Agreement (collectively, the “Modified Forms of Award Agreement”) for awards made on and after January 1, 2019. Performance Shares, if they vest at the end of a three-year performance period, are multiplied by a performance factor from zero to 175% and payable in shares of Company common stock (“Shares”). Performance Units are substantially similar to Performance Shares, but are paid in cash using the price of Shares. The Modified Forms of Award Agreement no longer allow the Committee to exercise discretion in determining the performance factor.
Read the 8-K filing - Dec 4, 2018
On December 3, 2018, the MetLife, Inc. (the “Company”) Board of Directors appointed Tamara L. Schock as Executive Vice President and Chief Accounting Officer. Ms. Schock’s appointment will be effective when her employment with a Company affiliate begins, which MetLife expects will be March 4, 2019. A copy of MetLife’s news release announcing Ms. Schock’s appointment is included in this report as Exhibit 99.1. Ms. Schock, age 47, has served as Chief Financial Officer of Exchange Income Corporation, a multi-national publicly listed Canadian company with businesses in the aviation, aerospace and manufacturing industries, since 2015. Ms.
Read the 8-K filing - Sep 27, 2018
On September 25, 2018, the MetLife, Inc. (the “Company”) Board of Directors (the “Board”) elected Diana McKenzie a director of the Company and appointed Ms. McKenzie to its Audit Committee and its Finance and Risk Committee, effective November 1, 2018. The Board also affirmatively determined that Ms. McKenzie qualifies as an independent director under the Corporate Governance Standards of the New York Stock Exchange. A copy of the news release issued by the Company on September 25, 2018 announcing Ms. McKenzie’s appointment is attached as Exhibit 99.1. Ms. McKenzie will participate in the Company’s standard non-management director compensation arrangements. The Company pays non-management directors a retainer of $300,000 per year, 50% in shares of the Company’s common stock and 50% in cash.
Read the 8-K filing - Jun 18, 2018
On June 12, 2018, the MetLife, Inc. (the “Company”) Board of Directors approved a Separation Agreement and General Release (the “Agreement”) with former Executive Vice President and Chief Financial Officer John C. R. Hele, and the Agreement became effective. Under the Agreement, Mr. Hele will remain employed by a Company affiliate in a special advisory capacity through September 30, 2018, unless he earlier ends his employment or the Company affiliate terminates him for cause as defined in the Agreement. During this time, Mr. Hele will continue to receive his base salary (at an annual rate of $815,000) and benefits, but he will not receive additional incentive awards. Mr.
Read the 8-K filing - May 18, 2018
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing - May 16, 2018
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing - May 7, 2018
The MetLife, Inc. Board of Directors appointed John McCallion Executive Vice President and Chief Financial Officer, to succeed the retiring John C.R. Hele, effective May 1, 2018. Mr. McCallion retained his title as Treasurer. A copy of MetLife’s May 1, 2018 news release announcing this and other senior leadership changes is included in this report as Exhibit 99.1. Mr. McCallion, age 44, joined MetLife in July 2006. He has served MetLife as Chief Financial Officer for Investments, head of Investor Relations, Chief Financial Officer for the Europe, the Middle East, and Africa region (“EMEA”) beginning in 2012, and Executive Vice President and Treasurer beginning in 2016. Mr. McCallion’s previous MetLife service in EMEA causes multi-jurisdiction tax complexity that persists for several years after his return to the U.S. As a result, on May 4, 2018, MetLife, Inc. agreed to provide Mr.
Read the 8-K filing - Feb 21, 2018
On February 20, 2018, the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) elected Gerald L. Hassell a director of the Company, effective immediately. Mr. Hassell was also appointed to serve on the Board’s Audit Committee, Compensation Committee, and Finance and Risk Committee, effective immediately. The Board has affirmatively determined that Mr. Hassell qualifies as an independent director under the Corporate Governance Standards of the New York Stock Exchange. A copy of the news release issued by the Company on February 20, 2018 announcing Mr. Hassell’s appointment is attached as Exhibit 99.1. Mr. Hassell will participate in the Company’s standard non-management director compensation arrangements.
Read the 8-K filing - Feb 20, 2018
On February 15, 2018, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of MetLife, Inc. (the “Company”) approved changes to the forms of award agreement and Award Agreement Supplement for stock-based long-term incentive compensation awards (collectively, the “Award Agreements”) under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan, effective February 27, 2018. Each of the Award Agreements has material terms that are substantially similar to those in the forms of award agreement last approved by the Committee and disclosed by the Company in its Annual Report on Form 10-K for the year ended December 31, 2015, except as noted below: • The Award Agreements exclude goals previously included for purposes of qualifying awards as performance-based compensation under U.S. Internal Revenue Code Section 162(m), and references to those goals.
Read the 8-K filing - Dec 21, 2017
On December 15, MetLife, Inc. (the “Company”) and Christopher Townsend, the Company’s former President, Asia, entered into an agreement (the “Agreement”) regarding Mr. Townsend’s resignation from the Company and its affiliates (“MetLife”). The Company’s Board of Directors previously approved the terms of the Agreement. The Agreement confirms that MetLife placed Mr. Townsend on paid garden leave effective November 7, 2017, consistent with the terms of his employment offer letter. It also confirms other terms of Mr. Townsend’s agreements with MetLife, and terms of Metlife’s programs, that apply to his departure, including: • Mr. Townsend will not receive an Annual Variable Incentive Plan award for 2017; • Mr.
Read the 8-K filing - Nov 6, 2017
MetLife, Inc.’s Board of Directors amended and restated the MetLife Performance-Based Compensation Recoupment Policy (the “Policy”), effective November 1, 2017. MetLife’s stock-based long-term incentive awards, annual cash incentive compensation, and other performance-based compensation to MetLife, Inc. executive officers and other employees (collectively, “Performance-Based Compensation”) is subject to the Policy in effect from time to time. Under the Policy, MetLife may seek to recoup Performance-Based Compensation: • from an employee who engaged in or contributed to fraudulent or other wrongful conduct, including by failure to appropriately supervise, that caused financial or reputational harm to MetLife, including a MetLife, Inc. accounting restatement required by material noncompliance with financial reporting requirements; and • from a MetLife, Inc.
Read the 8-K filing - Oct 31, 2017
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing - May 1, 2017
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing - Apr 17, 2017
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing - Oct 25, 2016
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2025 | $77.1B | $3.4B | 4.4% | $4.71 | $745.2B |
| FY2024 | $71.0B | $4.4B | 6.2% | $5.94 | $677.5B |
| FY2023 | $66.9B | $1.6B | 2.4% | $1.81 | $687.6B |
| FY2022 | $68.8B | $5.3B | 7.7% | $6.30 | $663.1B |
| FY2021 | $68.7B | $6.9B | 10.0% | $7.65 | $759.7B |
| FY2020 | $67.8B | $5.4B | 8.0% | $5.68 | $795.1B |
| FY2019 | $69.6B | $5.9B | 8.5% | $6.06 | $740.5B |
| FY2018 | $67.9B | $5.1B | 7.5% | $4.91 | $687.5B |
Former directors and officers (26)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.